HomeGUD • TSE
Follow
Knight Therapeutics Inc
Previous close
$5.44
Day range
$5.29 - $5.48
Year range
$4.30 - $5.75
Market cap
538.23M CAD
Avg Volume
81.00K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 81.50M | 12.75% |
Operating expense | 39.25M | -2.69% |
Net income | 9.59M | 502.64% |
Net profit margin | 11.76 | 434.55% |
Earnings per share | 0.09 | 13.12% |
EBITDA | 14.63M | 174.24% |
Effective tax rate | -7.75% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 159.93M | 2.25% |
Total assets | 1.01B | -2.34% |
Total liabilities | 196.48M | 8.66% |
Total equity | 814.66M | — |
Shares outstanding | 104.36M | — |
Price to book | 0.70 | — |
Return on assets | 0.23% | — |
Return on capital | 0.26% | — |
Cash Flow
Net change in cash
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | 9.59M | 502.64% |
Cash from operations | 15.17M | 28.61% |
Cash from investing | 35.76M | 1,184.83% |
Cash from financing | -11.24M | -101.09% |
Net change in cash | 39.57M | 354.72% |
Free cash flow | -4.72M | -167.27% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
725